Macquarie Group Limited (ASX:MQG) Announces FY25 Results and Dividend
Macquarie Group (ASX:MQG) reports a 2% increase in net operating income for FY25 and announces a $6.50 per share dividend.
Aeris Resources (ASX:AIS) Secures Refinancing of Facilities
Aeris Resources (ASX:AIS) refinances its facilities with a $60M Guarantee Facility from WHSP, enhancing liquidity and supporting growth.
Alvo Minerals (ASX:ALV) Advances Mineral Acquisitions and Exploration
Alvo Minerals (ASX:ALV) announces key acquisitions and exploration milestones, reinforcing its position in Brazil’s mineral sector.
Tempest Minerals Limited (ASX:TEM) Announces Inaugural Resource Estimate
Tempest Minerals (ASX:TEM) announces a 63.5 Mt @ 30.6% Fe inaugural resource estimate for the Remorse Deposit, paving the way for future development.
Challenger Gold Limited (ASX:CEL) Doubles El Guayabo Mineral Resource and Secures Investment Protection Agreement
Challenger Gold (ASX:CEL) doubles El Guayabo Project’s mineral resource to 9.1Moz AuEq and secures an Investment Protection Agreement with Ecuador’s government.
Smartgroup Corporation Ltd (ASX:SIQ) Reports 10% Revenue Growth in Q1 2025
Smartgroup Corporation Ltd (ASX:SIQ) reports a 10% revenue increase in Q1 2025, driven by strong novated leasing demand and strategic partnerships.
LTR Pharma Limited (ASX:LTP) Signs Collaborative Agreement for OROFLOW® Development
LTR Pharma (ASX:LTP) collaborates with SDS to develop OROFLOW®, a novel intranasal spray for Oesophageal Motility Disorders.
Geopacific Resources Limited (ASX:GPR) Unlocks New Porphyry Cu-Au Potential on Woodlark Island
Geopacific Resources (ASX:GPR) reveals 14 new porphyry Cu-Au targets at Woodlark Gold Project, boosting exploration prospects.
Credit Corp Group (ASX:CCP) Releases FY25 Market Update
Credit Corp Group (ASX:CCP) outlines its FY25 financial targets and strategic growth initiatives across US and Australian/NZ markets in its latest market update.
Regis Healthcare Limited (ASX:REG) Reports Strong H1 FY25 Financial Performance
Regis Healthcare Limited (ASX:REG) reports a 17.5% revenue increase in H1 FY25, highlighting significant growth and financial stability.